These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21554219)

  • 41. Hemoadsorption by CytoSorb in septic patients: a case series.
    Kogelmann K; Jarczak D; Scheller M; Drüner M
    Crit Care; 2017 Mar; 21(1):74. PubMed ID: 28343448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing oxygen delivery in the critically ill: assessment of volume responsiveness in the septic patient.
    de Witt B; Joshi R; Meislin H; Mosier JM
    J Emerg Med; 2014 Nov; 47(5):608-15. PubMed ID: 25088530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sepsis: clinical dilemmas.
    Murray MJ
    Yale J Biol Med; 1998; 71(6):485-91. PubMed ID: 10604781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ARC--augmented renal clearance.
    Udy AA; Putt MT; Boots RJ; Lipman J
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2020-9. PubMed ID: 21554215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of sepsis and multiple organ dysfunction syndrome in children.
    Proulx F; Fayon M; Farrell CA; Lacroix J; Gauthier M
    Chest; 1996 Apr; 109(4):1033-7. PubMed ID: 8635327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of tumor necrosis factor alpha polymorphism TNF-α
    Fatani SH; ALrefai AA; Al-Amodi HS; Kamel HF; Al-Khatieb K; Bader H
    Mol Biol Rep; 2018 Oct; 45(5):839-847. PubMed ID: 29978383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-volume haemofiltration for sepsis.
    Borthwick EM; Hill CJ; Rabindranath KS; Maxwell AP; McAuley DF; Blackwood B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008075. PubMed ID: 23440825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of therapy with recombinant human activated protein C of critically ill surgical patients with infection complicated by septic shock and multiple organ dysfunction syndrome.
    Barie PS; Hydo LJ; Shou J; Eachempati SR
    Surg Infect (Larchmt); 2011 Dec; 12(6):443-9. PubMed ID: 22185191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis.
    Book M; Chen Q; Lehmann LE; Klaschik S; Weber S; Schewe JC; Luepertz M; Hoeft A; Stuber F
    Crit Care; 2007; 11(1):R19. PubMed ID: 17302973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Personalised pharmacotherapy in intensive care unit patients].
    Bellmann R
    Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sepsis and septic shock.
    Ellrodt AG
    Emerg Med Clin North Am; 1986 Nov; 4(4):809-40. PubMed ID: 3536440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Personalised antibiotic therapy in a surgical intensive care unit overview of current knowledge and the results of an observational kinetic study].
    Kaška M; Martinková J; Havel E; Kočí J; Fousková A; Solichová D; Kujovská L; Selke-Krulichová I; Práznovec I; Salavec V
    Rozhl Chir; 2014 Sep; 93(9):456-62. PubMed ID: 25301344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bloodstream infection-associated sepsis and septic shock in critically ill adults: a population-based study.
    Laupland KB; Davies HD; Church DL; Louie TJ; Dool JS; Zygun DA; Doig CJ
    Infection; 2004 Apr; 32(2):59-64. PubMed ID: 15057568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies].
    Petejová N; Martínek A; Zahálková J; Duricová J; Plášek J; Valkovský I; Grundmann M; Kacířová I
    Vnitr Lek; 2012 Jun; 58(6):448-54. PubMed ID: 22913237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units.
    Jaruratanasirikul S; Thengyai S; Wongpoowarak W; Wattanavijitkul T; Tangkitwanitjaroen K; Sukarnjanaset W; Jullangkoon M; Samaeng M
    Antimicrob Agents Chemother; 2015; 59(6):2995-3001. PubMed ID: 25753628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
    Sinnollareddy MG; Roberts MS; Lipman J; Roberts JA
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):489-96. PubMed ID: 22519600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.